Sensyne Health logo

SENS - Sensyne Health Share Price

92.5p 0.5  0.5%

Last Trade - 4:42pm

Small Cap
Market Cap £118.3m
Enterprise Value £88.7m
Revenue £2.05m
Position in Universe 899th / 1803
Unlock SENS Revenue
Relative Strength (%)
1m +33.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -24.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Apr 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.081 0.14 2.05 8.84 24.0 +403.1%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 April 2020, Sensyne Health PLC revenues increased from £136K to £2.1M. Net loss before extraordinary items increased 15% to £21.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other general and administration expense increase of 60% to £9.8M (expense), Research and development expenses increase of 34% to £11.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SENS
Graphical History


SENS Revenue Unlock SENS Revenue

Net Income

SENS Net Income Unlock SENS Revenue

Normalised EPS

SENS Normalised EPS Unlock SENS Revenue

PE Ratio Range

SENS PE Ratio Range Unlock SENS Revenue

Dividend Yield Range

SENS Dividend Yield Range Unlock SENS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SENS EPS Forecasts Unlock SENS Revenue
Profile Summary

Sensyne Health plc is a United Kingdom-based healthcare technology company that provides digital health software products, such as SEND, EDGE:COPD, GDm-Health and Support-HF, and a software/device combination product (CleanSpace). SEND is used to record sign observations, including blood pressure, pulse rate, oxygen saturation, temperature, respiratory rate, responsiveness and the presence of an oxygen mask. EDGE:COPD is used to manage the care of patients suffering from chronic obstructive pulmonary disease (COPD). GDm-Health is a patient-to-clinician system for the management of diabetes in pregnancy. Support-HF is a digital health software system that underpins a remote patient management service for heart failure patients. CleanSpace is a research tool used to measure the exposure to pollution an individual has encountered over time and to crowd-source that information to provide a map of air pollution. It consists of physical tag and an application.

Last Annual April 30th, 2020
Last Interim April 30th, 2020
Incorporated June 20, 2018
Public Since August 17, 2018
No. of Shareholders: n/a
No. of Employees: 59
Sector Technology
Industry Software & IT Services
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 128,571,514
Free Float (0.0%)
Eligible for
SENS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SENS
Upcoming Events for SENS
Friday 30th October, 2020
Sensyne Health PLC Annual Shareholders Meeting
Thursday 29th October, 2020 Estimate
Sensyne Health PLC Annual Shareholders Meeting
Frequently Asked Questions for Sensyne Health
What is the Sensyne Health share price?

As of 4:42pm, shares in Sensyne Health are trading at 92.5p, giving the company a market capitalisation of £118.3m. This share price information is delayed by 15 minutes.

How has the Sensyne Health share price performed this year?

Shares in Sensyne Health are currently trading at 92.5p and the price has moved by -24.9% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sensyne Health price has moved by -9.31% over the past year.

What are the analyst and broker recommendations for Sensyne Health?

Of the analysts with advisory recommendations for Sensyne Health, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Sensyne Health is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Sensyne Health next release its financial results?

Sensyne Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-04-30
What is the Sensyne Health dividend yield?

Sensyne Health does not currently pay a dividend.

Does Sensyne Health pay a dividend?

Sensyne Health does not currently pay a dividend.

When does Sensyne Health next pay dividends?

Sensyne Health does not currently pay a dividend.

How do I buy Sensyne Health shares?

To buy shares in Sensyne Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sensyne Health?

Shares in Sensyne Health are currently trading at 92.5p, giving the company a market capitalisation of £118.3m.

Where are Sensyne Health shares listed? Where are Sensyne Health shares listed?

Here are the trading details for Sensyne Health:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SENS
What kind of share is Sensyne Health?

Based on an overall assessment of its quality, value and momentum, Sensyne Health is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sensyne Health share price forecast 2020?

Shares in Sensyne Health are currently priced at 92.5p. At that level they are trading at 0.147% discount to the analyst consensus target price of 92.64.

Analysts covering Sensyne Health currently have a consensus Earnings Per Share (EPS) forecast of -0.00055 for the next financial year.

How can I tell whether the Sensyne Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sensyne Health. Over the past six months, the relative strength of its shares against the market has been 75.2%. At the current price of 92.5p, shares in Sensyne Health are trading at 83.92% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sensyne Health PE Ratio?

We were not able to find PE ratio data for Sensyne Health.

Who are the key directors of Sensyne Health?

We were unable to find the directors for Sensyne Health.

Who are the major shareholders of Sensyne Health?

Here are the top five shareholders of Sensyne Health based on the size of their shareholding:

Lord Paul Radd Drayson Individual Investor
Percentage owned: 15.46% (19.9m shares)
Lady Elspeth Drayson Individual Investor
Percentage owned: 13.57% (17.4m shares)
Woodford Investment Management Ltd. Investment Advisor
Percentage owned: 11.8% (15.2m shares)
Acacia Research Corp Investment Advisor
Percentage owned: 11.8% (15.2m shares)
Lansdowne Partners (UK) LLP Investment Advisor/Hedge Fund
Percentage owned: 9.96% (12.8m shares)
Similar to SENS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.